CIK 0001641489 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | 0 | 2.0 M | ||
| Net income (USD) | -19.2 M | -13.0 M | -8.5 M |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-08 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-10-06 | 8-K | 8-K items 5.03,9.01 | 2026-10-01 |
| 2026-08-06 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-06 | 8-K | 8-K items 2.02,9.01 | 2026-08-06 |
| 2026-07-29 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-06-29 | 4 | 4 | 2026-06-26 |
| 2026-06-29 | 8-K | 8-K items 5.07 | 2026-06-26 |
| 2026-06-29 | 4 | FORM 4 | 2026-06-26 |
| 2026-06-29 | 4 | FORM 4 | 2026-06-26 |
| 2026-06-29 | 4 | FORM 4 | 2026-06-26 |
| 2026-06-29 | 4 | FORM 4 | 2026-06-26 |
| 2026-06-10 | DEFA14A | DEFA14A | |
| 2026-05-13 | 424B2 | 424B2 | |
| 2026-05-13 | 8-K | 8-K items 8.01,9.01 | 2026-05-13 |
| 2026-05-13 | S-8 | S-8 | |
| 2026-05-13 | 10-Q | 10-Q | 2026-03-31 |
| 2026-05-13 | 8-K | 8-K items 2.02,9.01 | 2026-05-13 |
| 2026-04-28 | DEF 14A | DEF 14A | 2026-06-10 |
| 2026-04-16 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-03-27 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-03-10 | 8-K | 8-K items 7.01,9.01 | 2026-03-10 |
| 2026-03-10 | 8-K | 8-K items 2.02,9.01 | 2026-03-10 |
| 2026-03-10 | 10-K | 10-K | 2025-12-31 |
| 2026-02-26 | 8-K | 8-K items 7.01,9.01 | 2026-02-26 |
| 2026-02-18 | 4 | FORM 4 | 2026-02-17 |
Forms on file (last 1,000): 8-K 173, 4 170, SC 13D/A 45, 10-Q 34, 3 33, CORRESP 13, UPLOAD 13, DEF 14A 11. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=VTVT (0.002 USD), /gw/filings/filings?ticker=VTVT&form=8-K, /gw/filings/facts?ticker=VTVT&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange